Health Care: Drugs

Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)

$100.57 -2.10 | -2.05%
05/22/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 1.13B 783.43M 540.96M 386.80M
Cost of Sales 102.74M 75.93M 47.68M 32.59M
Gross Operating Profit 1.03B 707.50M 493.27M 354.21M
Selling, General, and Administrative Expenses 384.68M 308.18M 227.49M 172.77M
Research & Development 222.73M 137.42M 98.39M 81.92M
Operating Income before D & A (EBITDA) 423.96M 261.90M 167.39M 99.53M
Depreciation & Amortization 23.89M 17.59M 16.75M 12.47M
Interest Income 1.84M 0.00 1.51M 0.00
Other Income - Net 52.17M -370.00K -2.43M -3.14M
Special Income / Charges -26.30M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 404.97M 230.46M 149.72M 83.92M
Interest Expense 7.40M 788.00K 704.00K 606.00K
Pre-Tax Income 397.57M 229.67M 149.01M 83.31M
Income Taxes 142.74M 54.35M 51.98M -211.85M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 254.82M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 254.82M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 254.82M 175.32M 97.03M 295.17M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 303.93M 13.49M 0.00 0.00
Preferred Dividends
Net Income Available To Common 254.82M 0.00 0.00 0.00
Basic EPS from Continuing Ops. 1.34 0.96 0.55 1.73
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.34 0.96 0.55 1.73
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.34 0.96 0.55 1.73
Basic Normalized Net Income/Share 1.60 n.a. n.a. n.a.
EPS fr Continuing Ops. 1.28 0.91 0.52 1.63
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.28 0.91 0.52 1.63
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.28 0.91 0.52 1.63
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.53 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALXN

View All

Latest ALXN Headlines from TheStreet

More Financial News for ALXN

Press Releases for ALXN

See All Press Releases

Partner Headlines for ALXN

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter